Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lannett Company Inc (NYSE:LCI)

24.08
BATS BZX Real-Time Price
As of 1:20pm ET
 +0.33 / +1.39%
Today’s Change
16.91
Today|||52-Week Range
62.90
-39.98%
Year-to-Date
Analysts Differ On Impact Of Valeant's Rejected Takeover Bid
May 27 / TheStreet.com - Paid Partner Content
3 Healthcare Stocks Bears Are Wrong About
May 18 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close23.75
Today’s open24.11
Day’s range23.71 - 24.46
Volume46,396
Average volume (3 months)1,161,362
Market cap$872.8M
Dividend yield--
Data as of 1:20pm ET, 05/31/2016

Growth & Valuation

Earnings growth (last year)+149.38%
Earnings growth (this year)-17.43%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+48.60%
P/E ratio12.0
Price/Sales5.42
Price/Book1.86

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...+0.05+0.64%
MGNXMacroGenics Inc+1.12+4.57%
FWPForward Pharma A/S+0.90+4.64%
RGENRepligen Corp-0.38-1.59%
Data as of 2:22pm ET, 05/31/2016

Financials

Next reporting dateSeptember 6, 2016
EPS forecast (this quarter)$0.62
Annual revenue (last year)$406.8M
Annual profit (last year)$149.9M
Net profit margin36.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Arthur P. Bedrosian
President &
Chief Operating Officer
Michael J. Bogda
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts

Partner Offers

Search for Jobs